PKM and hepatocellular carcinoma: For examples, Feng et al. showed that Simvastatin inhibited the HIF-1α/PPAR-γ/PKM2 axis, and further suppressed PKM2-mediated glycolysis, causing reduced proliferation and enhanced apoptosis in hepatocellular carcinoma cells [58].